DOCMF OTC
Dr. Martens plc
1W: -15.0%
1M: -15.0%
3M: -4.5%
YTD: -11.8%
1Y: -26.5%
3Y: -42.5%
5Y: -79.8%
$0.93
-0.00 (-0.39%)
Weekly Expected Move ±9.0%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$767M
-2.6% ▼
5Y CAGR: -0.2%
Gross Profit
$506M
-1.1% ▼
5Y CAGR: +3.0%
Operating Income
$60M
+7.5% ▲
5Y CAGR: -21.1%
Net Income
$24M
+430.2% ▲
5Y CAGR: -7.2%
EPS (Diluted)
$0.02
+386.0% ▲
5Y CAGR: -6.9%
EBITDA
$86M
-22.4% ▼
5Y CAGR: -10.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $908M | $1.0B | $877M | $788M | $767M |
| YoY Growth | +17.5% | +10.1% | -12.3% | -10.2% | -2.6% |
| Cost of Revenue | $366M | $436M | $374M | $276M | $259M |
| Gross Profit | $542M | $564M | $503M | $512M | $506M |
| Gross Margin | 59.7% | 56.4% | 57.3% | 65.0% | 66.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $309M | $373M | $376M | $100K | -$700K |
| Operating Expenses | $309M | $373M | $376M | $456M | $446M |
| Operating Income | $233M | $191M | $126M | $56M | $60M |
| Operating Margin | 25.6% | 19.1% | 14.4% | 7.1% | 7.9% |
| Interest Expense | $15M | $19M | $32M | $29M | $28M |
| Income Before Tax | $214M | $159M | $93M | $9M | $33M |
| Tax Expense | $33M | $30M | $24M | $4M | $9M |
| Net Income | $181M | $129M | $69M | $4M | $24M |
| Net Margin | 19.9% | 12.9% | 7.9% | 0.6% | 3.1% |
| EPS (Diluted) | $0.18 | $0.13 | $0.07 | $0.01 | $0.02 |
| EBITDA | $266M | $204M | $196M | $110M | $86M |
| Shares Outstanding | 1.00B | 1.00B | 986M | 974M | 980M |